With President Donald Trump expected to deliver a drug pricing order on Monday that Big Pharma and patient groups alike have ...

Cantor Fitzgerald gave Regeneron a financial pick-me-up by nudging its 2025 EPS forecast to $26.88 from $26.38. This slight ...

Fintel reports that on May 7, 2025, Leerink Partners upgraded their outlook for Amylyx Pharmaceuticals (NasdaqGS:AMLX) from Market Perform to Outperform. As of May 7, 2025, the average one-year ...

Fintel reports that on May 6, 2025, Leerink Partners downgraded their outlook for Vertex Pharmaceuticals (WBAG:VRTX) from Outperform to Market Perform. There are 2,792 funds or institutions ...

In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other cheap ESG stocks. These days, it seems like everyone wants to wear the ...

How Does Regeneron Pharmaceuticals P/E Compare to Other Companies? The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's ...